The asthma drugs market is projected to reach US$ 34,136.10 million in 2028 from US$ 24,239.17 million in 2021; it is estimated to grow at a CAGR of 5.0 % during 2021–2028.
Asthma is a lung disease that affects people of all ages. It produces wheezing and makes breathing difficult. Exposure to an allergy or irritant, infections, exercise, emotional stress, and other conditions are all potential triggers. When the symptoms of asthma become unbearable, an asthma attack ensues. Attacks can happen out of nowhere and range from mild to life-threatening. Asthma is managed with rescue inhalers to treat symptoms and controller inhalers that prevent symptoms. Severe cases may require longer-acting inhalers that keep the airways open (formoterol, salmeterol, tiotropium) and inhalant steroids. Asthma medication comes in several forms, including tablets, injections, liquids, and inhalers, and it falls into two groups, such as bronchodilators and anti-inflammatories.
The asthma drug market is segmented on the basis of medication, route of administration, distribution channel, and geography. The market, based on geography, is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The asthma drugs market report offers insights and in-depth analysis of the market, emphasizing parameters such as market size, trends, and dynamics; technological advancements in the market; and the analysis of the competitive landscape of the leading market players in the asthma drugs market.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Asthma Drugs Market: Strategic Insights
Market Size Value in US$ 24,239.17 Million in 2021 Market Size Value by US$ 34,136.10 Million in 2028 Growth rate CAGR of 5.0 % from 2021 to 2028 Forecast Period 2021-2028 Base Year 2021
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Asthma Drugs Market: Strategic Insights
| Market Size Value in | US$ 24,239.17 Million in 2021 |
| Market Size Value by | US$ 34,136.10 Million in 2028 |
| Growth rate | CAGR of 5.0 % from 2021 to 2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
A few factors such as the growing environmental implications & genetic implications of air pollution, more vulnerability in specific ethnic groups, growing exposure to coarse particulate matters, growing prevalence of physiological disorders harboring asthma are expected to have a significant short-, mid-, and long-term impact on the asthma drugs market in the coming years. However, unmet medical needs and lack of treatment adherence hamper the market growth. The market report identifies opportunities and future market trends that can have possible impacts on market growth.
Lucrative Regions in Asthma Drugs Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Growing Environmental Implications & Genetic Implications of Air Pollution
Asthma is a chronic respiratory condition marked by fluctuating airflow restriction, bronchial hyperresponsiveness, and airways inflammation. According to a review paper titled “Impact of Air Pollution on Asthma Outcomes” by Tiotiu et.al., air pollution hampered asthma outcomes in adults and children. Air pollution from traffic, nitrogen dioxide (NO2), and secondhand smoking (SHS) are all substantial risk factors for the development of asthma in children. Asthma symptoms, exacerbations, and decreased lung function can be triggered by exposure to outside pollution.
In the US, exposure to air pollution continues to be associated with asthma. This severe and life-threatening chronic respiratory condition impacts the quality of life of more than ~23 million American citizens. Air pollution can aggravate asthma symptoms, triggering asthma attacks among people. Children with asthma, which affects ~6 million children in the US, are particularly vulnerable to pollution.
A new study financed by the Environmental Protection Agency (EPA) analyzed the link between air pollution and asthma. While experts cannot determine the primary asthma-causing agent due to air pollution, evidence suggests that it suppresses genes that control the immune system to distinguish between an allergen and a hazardous foreign substance, such as a virus or bacteria. The immune system then goes into overdrive, triggering an inflammatory reaction regardless of whether the drug is toxic, resulting in asthma.
Researchers from Stanford University's Children's Center investigated the effect of air pollution on two genes involved in immunological tolerance in children from an area with high levels of pollution. They discovered that short- and long-term exposure to high amounts of carbon monoxide (CO), NO2, and PM2.5 (particulate matter) were linked to changes in these two genes, which caused asthma. These findings focused on the epigenetic impacts of air pollution exposure and could help in the development of preventative asthma medicines.
Each of these asthma research has improved the understanding of asthma in children and supplied crucial information to the EPA that can be used to protect human health and the environment. Through these research works, the drug discovery and development for asthma is being expedited, which is driving the asthma drug market.
Medication Type-Based Insights
The global asthma drugs market, based on medications, is bifurcated into quick relief medications and long-term control medications. The long-term control medications segment is expected to hold a larger share of the market in the coming years. However, the quick relief medications segment is expected to register a higher CAGR during the forecast period.
Asthma Drugs Market, by Medication – 2021 and 2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Route of Administration-Based Insights
Based on route of administration, the asthma drugs market is segmented into inhaled, prefilled syringe/vials, and others. The inhaled segment held the largest share of the market in 2021 and is expected to hold a significant share during the forecast period. However, the prefilled syringe/vials segment is expected to register the highest CAGR from 2021 to 2028.
Distribution Channel-Based Insights
Based on distribution channel, the asthma drugs market is segmented into online pharmacies, hospital pharmacies, and retail pharmacies. The retail pharmacies segment is expected to hold the largest share of the market during the forecast period. However, the online pharmacies segment is expected to register the highest CAGR during 2021–2028.
Various companies operating in the asthma drugs market adopt strategies such as product launches, mergers and acquisitions, collaborations, product innovations, and product portfolio expansions to expand their footprint worldwide, maintain a brand name, and meet growing consumer demands. Some of the leading players present in the market are AstraZeneca; Teva Pharmaceutical Industries Ltd.; GlaxoSmithKline PLC; Boehringer Ingelheim International GmbH; Merck & Co., Inc.; Koninklijke Philips NV; Sanofi; Pfizer Inc.; Novartis AG; and Abbott.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Medications, Route of Administration, and Distribution Channels
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Asthma is a lung disease that affects people of all ages. It produces wheezing and makes breathing difficult. Exposure to an allergy or irritant, infections, exercise, emotional stress, and other conditions are all potential triggers. When the symptoms of asthma become unbearable, an asthma attack ensues. Attacks can happen out of nowhere and range in severity from mild to life-threatening. Asthma is managed with rescue inhalers to treat symptoms and controller inhalers that prevent symptoms. Severe cases may require longer-acting inhalers that keep the airways open (formoterol, salmeterol, tiotropium), as well as inhalant steroids. Asthma drugs come in several forms, including tablets, injections, liquids, and inhalers; and it falls into two groups: bronchodilators and anti-inflammatories.
The global asthma drugs market is being driven by factors such as growing environmental implications & genetic implications of air pollution, more vulnerability in specific ethnic groups, growing exposure to coarse particulate matters, and the growing prevalence of physiological disorders harboring asthma.
The unmet medical needs and the lack of treatment adherence are the leading restraints that will hinder the asthma drugs market growth.
The asthma drugs market comprises of players that include AstraZeneca, TEVA PHARMACEUTICAL INDUSTRIES LTD, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Merck & Co., Inc, Koninklijke Philips N.V., Sanofi, Pfizer Inc., Novartis AG, and Abbott are among others.
The asthma drugs market on the basis of medication is bifurcated into quick relief medications and long-term control medications. In 2021, the long-term control medications segment accounted for a larger share in the global asthma drugs market.
On the basis of route of administration, the asthma drugs market is segmented into inhaled, prefilled syringe/vials, and others. The inhaled segment is expected to hold the largest share from 2021 to 2028. However, the prefilled syringe/vials segment is expected to grow at the highest CAGR during the forecast period.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Asthma Drugs Market – By Medication
1.3.2 Global Asthma Drugs Market – By Route of Administration
1.3.3 Global Asthma Drugs Market – By Distribution Channel
1.3.4 Global Asthma Drugs Market – By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Asthma Drugs Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East & Africa – PEST Analysis
4.2.5 South and Central America– PEST Analysis
4.3 Expert Opinion
5. Asthma Drugs Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Environmental Implications & Genetic Implications of Air Pollution
5.1.2 More Vulnerability in Specific Ethnic Groups
5.1.3 Growing Exposure to Coarse Particulate Matters
5.1.4 Growing Prevalence of Physiological Disorders Harboring Asthma
5.2 Market Restraints
5.2.1 Unmet Medical Needs
5.2.2 Lack of Treatment Adherence
5.3 Market Opportunities
5.3.1 Opportunities with Commercialization of Biologics
5.4 Future Trends
5.4.1 Increasing Research Activities and Product Innovations
5.5 Impact Analysis
6. Asthma Drugs Market– Global Analysis
6.1 Global Asthma Drugs Market Revenue Forecast and Analysis
6.1.1 Global Asthma Drugs Market Revenue Forecast and Analysis
6.1.2 Global Asthma Drugs Market Revenue Forecast and Analysis
6.1.3 Global Asthma Drugs Market – Market Potential Analysis, By Region
6.2 Company Analysis
6.2.1 Market Positioning of Key Players
6.2.2 Comparative Company Analysis
6.2.3 Growth Strategy Analysis
6.2.4 Performance of Key Players
6.2.4.1 Pfizer Inc.
6.2.4.2 GlaxoSmithKline plc
7. Asthma Drugs Market Analysis – by Medication
7.1 Overview
7.2 Asthma Drugs Market Revenue Share, by Medication (2021 and 2028)
7.3 Quick Relief Medications
7.3.1 Overview
7.3.2 Quick Relief Medications: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Long-term Control Medications
7.4.1 Overview
7.4.2 Long-term Control Medications: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)
8. Asthma Drugs Market Analysis – By Route of Administration
8.1 Overview
8.2 Asthma Drugs Market Revenue Share, By Route of Administration (2021 and 2028)
8.3 Inhaled
8.3.1 Overview
8.3.2 Inhaled: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
8.4 Prefilled Syringe/Vials
8.4.1 Overview
8.4.2 Prefilled Syringe/Vials: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
8.5 Others (Oral, Nasal, Ophthalmic Etc.)
8.5.1 Overview
8.5.2 Others: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
9. Asthma Drugs Market Analysis – By Distribution Channel
9.1 Overview
9.2 Asthma Drugs Market Revenue Share, By Distribution Channel (2021 and 2028)
9.3 Online Pharmacies
9.3.1 Overview
9.3.2 Online Pharmacies: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
9.4 Hospital Pharmacies
9.4.1 Overview
9.4.2 Hospital Pharmacies: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
9.5 Retail Pharmacies and Drugstores
9.5.1 Overview
9.5.2 Retail Pharmacies and Drugstores: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
10. Asthma Drugs Market – Geographical Analysis
10.1 North America: Asthma Drugs Market Revenue and Forecast to 2028
10.1.1 Overview
10.1.2 North America: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.1.3 North America: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)
10.1.4 North America: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)
10.1.5 North America: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.6 North America: Asthma Drugs Market, by Country, 2021 & 2028 (%)
10.1.6.1 US: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.1 US: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.2 US: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)
10.1.6.1.3 US: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)
10.1.6.1.4 US: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.6.2 Canada: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.1 Canada: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.2 Canada: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)
10.1.6.2.3 Canada: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)
10.1.6.2.4 Canada: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.6.3 Mexico: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.1 Mexico: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.2 Mexico: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)
10.1.6.3.3 Mexico: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)
10.1.6.3.4 Mexico: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)
10.2 Europe
10.2.1 Overview
10.2.2 Europe: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.2.3 Europe: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)
10.2.4 Europe: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)
10.2.5 Europe: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)
10.2.6 Europe: Asthma Drugs Market, by Country, 2021 & 2028 (%)
10.2.6.1 Germany: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.1.1 Germany: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.1.2 Germany: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)
10.2.6.1.3 Germany: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)
10.2.6.1.4 Germany: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)
10.2.6.2 UK: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.2.1 UK: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.2.2 UK: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)
10.2.6.2.3 UK: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)
10.2.6.2.4 UK: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)
10.2.6.3 France: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.3.1 France: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.3.2 France: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)
10.2.6.3.3 France: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)
10.2.6.3.4 France: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)
10.2.6.4 Italy: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.4.1 Italy: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.4.2 Italy: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)
10.2.6.4.3 Italy: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)
10.2.6.4.4 Italy: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)
10.2.6.5 Spain: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.5.1 Spain: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.5.2 Spain: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)
10.2.6.5.3 Spain: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)
10.2.6.5.4 Spain: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)
10.2.6.6 Rest of Europe: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.6.1 Rest of Europe: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.6.2 Rest of Europe: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)
10.2.6.6.3 Rest of Europe: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)
10.2.6.6.4 Rest of Europe: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)
10.3 Asia Pacific: Asthma Drugs Market
10.3.1 Overview
10.3.2 Asia Pacific: Asthma Drugs Market - Revenue and Forecast to 2028 (USD Million)
10.3.3 Asia Pacific: Asthma Drugs Market, by Medication - Revenue and Forecast to 2028 (USD Million)
10.3.4 Asia Pacific: Asthma Drugs Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
10.3.5 Asia Pacific: Asthma Drugs Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
10.3.6 Asia Pacific Asthma Drugs Market Revenue and Forecasts to 2028, By Country (%)
10.3.6.1 India Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)
10.3.6.1.1 India Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)
10.3.6.1.2 India: Asthma Drugs Market, by Medication - Revenue and Forecast to 2028 (USD Million)
10.3.6.1.3 India: Asthma Drugs Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
10.3.6.1.4 India: Asthma Drugs Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
10.3.6.2 China Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)
10.3.6.2.1 China Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)
10.3.6.2.2 China: Asthma Drugs Market, by Medication - Revenue and Forecast to 2028 (USD Million)
10.3.6.2.3 China: Asthma Drugs Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
10.3.6.2.4 China: Asthma Drugs Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
10.3.6.3 Japan Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)
10.3.6.3.1 Japan Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)
10.3.6.3.2 Japan: Asthma Drugs Market, by Medication - Revenue and Forecast to 2028 (USD Million)
10.3.6.3.3 Japan: Asthma Drugs Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
10.3.6.3.4 Japan: Asthma Drugs Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
10.3.6.4 South Korea: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Thousand)
10.3.6.4.1 South Korea: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.2 South Korea: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (US$ Thousand)
10.3.6.4.3 South Korea: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Thousand)
10.3.6.4.4 South Korea: Asthma Drugs Market, by Distribution channel – Revenue and Forecast to 2028 (US$ Thousand)
10.3.6.5 Australia: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Thousand)
10.3.6.5.1 Australia: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.2 Australia: Asthma Drugs Market, by Medication– Revenue and Forecast to 2028 (US$ Thousand)
10.3.6.5.3 Australia: Asthma Drugs Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Thousand)
10.3.6.5.4 Australia: Asthma Drugs Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Thousand)
10.3.6.6 Rest of Asia Pacific Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)
10.3.6.6.1 Rest of Asia Pacific Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)
10.3.6.6.2 Rest of Asia Pacific: Asthma Drugs Market, by Medication - Revenue and Forecast to 2028 (USD Million)
10.3.6.6.3 Rest of Asia Pacific: Asthma Drugs Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
10.3.6.6.4 Rest of Asia Pacific: Asthma Drugs Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
10.4 Middle East & Africa: Asthma Drugs Market
10.4.1 Middle East & Africa: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
10.4.2 Middle East & Africa: Asthma Drugs Market, by Medication - Revenue and Forecast to 2028 (USD Million)
10.4.3 Middle East & Africa: Asthma Drugs Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
10.4.4 Middle East & Africa: Asthma Drugs Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
10.4.5 Middle East & Africa Asthma Drugs Market Revenue and Forecasts to 2028, By Country (%)
10.4.5.1 UAE: Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Million)
10.4.5.1.1 Overview
10.4.5.1.2 UAE: Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Million)
10.4.5.1.3 UAE: Asthma Drugs Market Revenue and Forecasts to 2028, By Medication (US$ Million)
10.4.5.1.3.1 UAE: Asthma Drugs Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
10.4.5.1.3.2 UAE: Asthma Drugs Market Revenue and Forecasts To 2028, By Distribution Channel (US$ Million)
10.4.5.2 Saudi Arabia: Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Million)
10.4.5.2.1 Overview
10.4.5.2.2 Saudi Arabia: Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Million)
10.4.5.2.3 Saudi Arabia: Asthma Drugs Market Revenue and Forecasts to 2028, By Medication (US$ Million)
10.4.5.2.3.1 Saudi Arabia: Asthma Drugs Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
10.4.5.2.3.2 Saudi Arabia: Asthma Drugs Market Revenue and Forecasts To 2028, By Distribution Channel (US$ Million)
10.4.5.3 South Africa: Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Million)
10.4.5.3.1 Overview
10.4.5.3.2 South Africa Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Million)
10.4.5.3.3 South Africa: Asthma Drugs Market Revenue and Forecasts to 2028, By Medication (US$ Million)
10.4.5.3.3.1 South Africa: Asthma Drugs Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
10.4.5.3.3.2 South Africa: Asthma Drugs Market Revenue and Forecasts To 2028, By Distribution Channel (US$ Million)
10.4.5.4 Rest of Middle East & Africa Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)
10.4.5.4.1 Rest of Middle East & Africa Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)
10.4.5.4.2 Rest of Middle East & Africa: Asthma Drugs Market, by Medication - Revenue and Forecast to 2028 (USD Million)
10.4.5.4.3 Rest of Middle East & Africa: Asthma Drugs Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
10.4.5.4.4 Rest of Middle East & Africa: Asthma Drugs Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
10.5 South and Central America: Asthma Drugs Market Revenue and Forecast to 2028
10.5.1 Overview
10.5.2 South and Central America: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.5.3 South and Central America: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)
10.5.4 South and Central America: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)
10.5.5 South and Central America: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)
10.5.6 South and Central America: Asthma Drugs Market, by Country, 2021 & 2028 (%)
10.5.6.1 Brazil: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.1.1 Brazil: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.1.2 Brazil: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)
10.5.6.1.3 Brazil: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)
10.5.6.1.4 Brazil: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)
10.5.6.2 Argentina: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.2.1 Argentina: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.2.2 Argentina: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)
10.5.6.2.3 Argentina: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)
10.5.6.2.4 Argentina: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)
10.5.6.3 Rest of South & Central America: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.3.1 Rest of South & Central America: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.3.2 Rest of South & Central America: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)
10.5.6.3.3 Rest of South & Central America: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)
10.5.6.3.4 Rest of South & Central America: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)
11. Impact of COVID-19 Pandemic on Global Asthma Drugs Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South & Central America: Impact Assessment of COVID-19 Pandemic
12. Asthma Drugs Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Asthma Drugs Market (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 AstraZeneca
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 TEVA PHARMACEUTICAL INDUSTRIES LTD
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 GlaxoSmithKline plc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Boehringer Ingelheim International GmbH
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Merck & Co., Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Koninklijke Philips N.V.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Sanofi
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Pfizer Inc. (Arena Pharmaceutical GmbH)
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Novartis AG
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Abbott
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Odds Ratio (OR) For Mental Disorders among Adults with Asthma Vs Without Asthma
Table 2. Asthma Death Rates for Select Countries, 2018
Table 3. Common SABAs
Table 4. Commonly inhaled corticosteroids
Table 5. North America: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)
Table 6. North America: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 7. North America: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 8. US: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)
Table 9. US: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 10. US: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 11. Canada: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)
Table 12. Canada: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 13. Canada: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 14. Mexico: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)
Table 15. Mexico: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 16. Mexico: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 17. Europe: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)
Table 18. Europe: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 19. Europe: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 20. Germany: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)
Table 21. Germany: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 22. Germany: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 23. UK: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)
Table 24. UK: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 25. UK: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 26. France: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)
Table 27. France: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 28. France: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 29. Italy: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)
Table 30. Italy: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 31. Italy: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 32. Spain: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)
Table 33. Spain: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 34. Spain: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 35. Rest of Europe: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)
Table 36. Rest of Europe: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 37. Rest of Europe: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 38. Asia Pacific Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)
Table 39. Asia Pacific Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 40. Asia Pacific Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 41. India Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)
Table 42. India Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 43. India Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 44. China Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)
Table 45. China Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 46. China Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 47. Japan Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)
Table 48. Japan Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 49. Japan Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 50. South Korea Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (US$ Thousand)
Table 51. South Korea Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Thousand)
Table 52. South Korea Asthma Drugs Market, by Distribution channel – Revenue and Forecast to 2028 (US$ Thousand)
Table 53. Australia Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (US$ Thousand)
Table 54. Australia Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Thousand)
Table 55. Australia Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Thousand)
Table 56. Rest of Asia Pacific Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)
Table 57. Rest of Asia Pacific Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 58. Rest of Asia Pacific Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 59. Middle East & Africa Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)
Table 60. Middle East & Africa Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 61. Middle East & Africa Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 62. UAE: Asthma Drugs Market Revenue and Forecasts to 2028, By Medication (US$ Million)
Table 63. UAE: Asthma Drugs Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 64. UAE: Asthma Drugs Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
Table 65. Saudi Arabia: Asthma Drugs Market Revenue and Forecasts to 2028, By Medication (US$ Million)
Table 66. Saudi Arabia: Asthma Drugs Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 67. Saudi Arabia: Asthma Drugs Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
Table 68. South Africa Asthma Drugs Market Revenue and Forecasts to 2028, By Medication (US$ Million)
Table 69. South Africa: Asthma Drugs Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 70. South Africa: Asthma Drugs Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
Table 71. Rest of Middle East & Africa Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)
Table 72. Rest of Middle East & Africa Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 73. Rest of Middle East & Africa Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 74. South and Central America: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)
Table 75. South and Central America: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 76. South and Central America: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 77. Brazil: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)
Table 78. Brazil: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 79. Brazil: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 80. Argentina: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)
Table 81. Argentina: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 82. Argentina: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 83. Rest of South & Central America: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)
Table 84. Rest of South & Central America: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 85. Rest of South & Central America: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 86. Organic Developments in the Asthma Drugs Market
Table 87. Inorganic Developments in the Asthma Drugs Market
Table 88. Glossary of Terms, Asthma Drugs Market
LIST OF FIGURES
Figure 1. Asthma Drugs Market Segmentation
Figure 2. Asthma Drugs Market, By Geography
Figure 3. Global Asthma Drugs Market Overview
Figure 4. The Long Term Control Medications Segment Held Largest Share of Mode of Service in the Asthma Drugs Market
Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Asthma Drugs Market, by Geography (US$ Million)
Figure 7. Global Asthma Drugs Market- Leading Country Markets (US$ Million)
Figure 8. Global Asthma Drugs Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East & Africa PEST Analysis
Figure 13. South and Central America PEST Analysis
Figure 14. Expert Opinion
Figure 15. Impact of Low Mood/Anxiety on Asthma
Figure 16. Adherence to ICS or ICS/LABA
Figure 17. Asthma Drugs Market Impact Analysis of Drivers and Restraints
Figure 18. Global Asthma Drugs Market– Revenue Forecast and Analysis – 2020- 2028
Figure 19. Global Asthma Drugs Market– Revenue Forecast and Analysis – 2021 - 2028
Figure 20. Global Asthma Drugs Market – Market Potential Analysis, By Region
Figure 21. Market Positioning of Key Players in Global Asthma Drugs Market
Figure 22. Global Asthma Drugs Market – Comparative Company Analysis
Figure 23. Global Asthma Drugs Market – Growth Strategy Analysis
Figure 24. Asthma Drugs Market Revenue Share, by Medication (2021 and 2028)
Figure 25. Quick Relief Medications: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Long-term Control Medications: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Asthma Drugs Market Share, By Route of Administration, 2021 and 2028 (%)
Figure 28. Inhaled: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
Figure 29. Prefilled Syringe/Vials: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
Figure 30. Others: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
Figure 31. Asthma Drugs Market Share, By Distribution Channel, 2021 and 2028 (%)
Figure 32. Online Pharmacies: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
Figure 33. Hospital Pharmacies: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
Figure 34. Retail Pharmacies and Drugstores: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)
Figure 35. North America: Asthma Drugs Market, by Key Country – Revenue (2021) (USD Million)
Figure 36. North America: Asthma Drugs Market Revenue and Forecast to 2028 (USD Million)
Figure 37. North America: Asthma Drugs Market, by Country, 2021 & 2028 (%)
Figure 38. Prevalence of Asthma by Age, Sex, and Race/Ethnicity, 2019
Figure 39. US: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
Figure 40. Prevalence of Diagnosed Asthma Among Canadians (%), By Age Group and Sex, 2011-12
Figure 41. Age-Standardized Prevalence of Diagnosed Asthma Among Canadians, by Sex and Year
Figure 42. Canada: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
Figure 43. Mexico: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
Figure 44. Europe: Asthma Drugs Market, by Key Country – Revenue (2021) (USD Million)
Figure 45. Europe: Asthma Drugs Market Revenue and Forecast to 2028 (USD Million)
Figure 46. Europe: Asthma Drugs Market, by Country, 2021 & 2028 (%)
Figure 47. Germany: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
Figure 48. UK: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
Figure 49. France: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
Figure 50. Italy: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
Figure 51. Spain: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
Figure 52. Rest of Europe: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
Figure 53. Asia Pacific: Asthma Drugs Market, by Key Country – Revenue (2021) (USD Million)
Figure 54. Asia Pacific Asthma Drugs Market Revenue and Forecast to 2028 (USD Million)
Figure 55. Asia Pacific Asthma Drugs Market Revenue and Forecasts to 2028, By Country (%)
Figure 56. India Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 57. China Asthma Drugs Products Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 58. Japan Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 59. South Korea: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 60. Australia: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 61. Rest of Asia Pacific Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 62. Middle East & Africa: Asthma Drugs Market, by Key Country – Revenue (2020) (USD Million)
Figure 63. Middle East & Africa Asthma Drugs Market Revenue and Forecast to 2028 (USD Million)
Figure 64. Middle East & Africa Asthma Drugs Market Revenue and Forecasts to 2028, By Country (%)
Figure 65. UAE: Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 66. Saudi Arabia: Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Million)
Figure 67. South Africa: Asthma Drugs Market Revenue and Forecasts to 2028 (US$ Million)
Figure 68. Rest of Middle East & Africa Asthma Drugs Products Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 69. South and Central America: Asthma Drugs Market, by Key Country – Revenue (2021) (USD Million)
Figure 70. South and Central America: Asthma Drugs Market Revenue and Forecast to 2028 (USD Million)
Figure 71. South and Central America: Asthma Drugs Market, by Country, 2021 & 2028 (%)
Figure 72. Brazil: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
Figure 73. Argentina: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
Figure 74. Rest of South & Central America: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)
Figure 75. Symptomatic Assessment to Differentiate Between COVID-19, Asthma, Flu, Cold, and Seasonal Allergies
Figure 76. Impact of COVID-19 Pandemic in North American Country Markets
Figure 77. Impact of COVID-19 Pandemic in European Country Markets
Figure 78. Impact of COVID-19 Pandemic in Asia Pacific Countries
Figure 79. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 80. Impact of COVID-19 Pandemic in South & Central American Country Markets
Figure 81. Growth Strategies in the Asthma Drugs Market (%)
The List of Companies - Asthma Drugs Market
- AstraZeneca
- TEVA PHARMACEUTICAL INDUSTRIES LTD.
- GlaxoSmithKline plc
- Boehringer Ingelheim International GmbH
- Merck & Co., Inc.
- Koninklijke Philips NV
- Sanofi
- Pfizer Inc.
- Novartis AG
- Abbott
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Asthma Drugs Market
Apr 2022
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2022
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2022
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2022
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2022
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2022
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Apr 2022
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Apr 2022
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)